Provided By PR Newswire
Last update: Jan 8, 2024
NEW YORK, Jan. 8, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Axonics, Inc. (NASDAQ: AXNX) and its board of directors concerning the proposed acquisition of the company by Boston Scientific Corporation (NYSE: BSX). Stockholders will receive $71.00 for each share of Axonics stock that they hold. The transaction is valued at approximately $3.7 billion and is expected to close in the first half of 2024.
Read more at prnewswire.comNYSE:BSX (7/1/2025, 12:23:07 PM)
104.91
-2.5 (-2.33%)
Find more stocks in the Stock Screener
Boston Scientific Corp (NYSE:BSX) shows strong technical and fundamental growth, fitting Minervini’s trend template with high earnings momentum and improving margins. A top pick for momentum investors.
Boston Scientific Corp (NYSE:BSX) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has solid support levels and consolidation patterns ahead of a potential breakout.